iShares U.S. Pharmaceuticals ETF (IHE)
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index measures the performance of the pharmaceuticals sector of the U.S. equity market. The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines. The fund is non-diversified.
$706.62M
May 01, 2006
7.14
$10.11
0.00
0.00
15.99%
0.00%
0.00
0.00
0.00
0.00
0.00%
0.00%
Sector weights (11)
Health Care Select Sector SPDR Fund
XLV
100%
Utilities Select Sector SPDR Fund
XLU
0%
Technology Select Sector SPDR Fund
XLK
0%
The Real Estate Select Sector SPDR Fund
XLRE
0%
Industrial Select Sector SPDR Fund
XLI
0%
Financial Select Sector SPDR Fund
XLF
0%
Energy Select Sector SPDR Fund
XLE
0%
Consumer Staples Select Sector SPDR Fund
XLP
0%
Consumer Discretionary Select Sector SPDR Fund
XLY
0%
Communication Services Select Sector SPDR Fund
XLC
0%
Materials Select Sector SPDR Fund
XLB
0%
ETF Constituents (30)
Johnson & Johnson
JNJ
23.768%
Eli Lilly and Company
LLY
22.046%
Bristol-Myers Squibb Company
BMY
4.92%
Viatris Inc.
VTRS
4.599%
Pfizer Inc.
PFE
4.319%
Royalty Pharma plc
RPRX
4.291%
Catalent, Inc.
CTLT
4.16%
Merck & Co., Inc.
MRK
3.816%
Elanco Animal Health Incorporated
ELAN
2.887%
Intra-Cellular Therapies, Inc.
ITCI
2.706%
Organon & Co.
OGN
2.091%
Prestige Consumer Healthcare Inc.
PBH
1.426%
Axsome Therapeutics, Inc.
AXSM
1.389%
Corcept Therapeutics Incorporated
CORT
1.189%
Supernus Pharmaceuticals, Inc.
SUPN
0.719%
Ligand Pharmaceuticals Incorporated
LGND
0.663%
Amphastar Pharmaceuticals, Inc.
AMPH
0.659%
Arvinas, Inc.
ARVN
0.65%
Cassava Sciences, Inc.
SAVA
0.505%
Collegium Pharmaceutical, Inc.
COLL
0.468%
Edgewise Therapeutics, Inc.
EWTX
0.466%
Harmony Biosciences Holdings, Inc.
HRMY
0.43%
Innoviva, Inc.
INVA
0.406%
Amneal Pharmaceuticals, Inc.
AMRX
0.367%
ANI Pharmaceuticals, Inc.
ANIP
0.355%
Tarsus Pharmaceuticals, Inc.
TARS
0.314%
Pliant Therapeutics, Inc.
PLRX
0.267%
Revance Therapeutics, Inc.
RVNC
0.261%
Pacira BioSciences, Inc.
PCRX
0.26%
Nuvation Bio Inc.
NUVB
0.178%
Sector weights (11)
Health Care Select Sector SPDR Fund
XLV
100%
Utilities Select Sector SPDR Fund
XLU
0%
Technology Select Sector SPDR Fund
XLK
0%
The Real Estate Select Sector SPDR Fund
XLRE
0%
Industrial Select Sector SPDR Fund
XLI
0%
Financial Select Sector SPDR Fund
XLF
0%
Energy Select Sector SPDR Fund
XLE
0%
Consumer Staples Select Sector SPDR Fund
XLP
0%
Consumer Discretionary Select Sector SPDR Fund
XLY
0%
Communication Services Select Sector SPDR Fund
XLC
0%
Materials Select Sector SPDR Fund
XLB
0%
ETF Constituents (30)
Johnson & Johnson
JNJ
23.768%
Eli Lilly and Company
LLY
22.046%
Bristol-Myers Squibb Company
BMY
4.92%
Viatris Inc.
VTRS
4.599%
Pfizer Inc.
PFE
4.319%
Royalty Pharma plc
RPRX
4.291%
Catalent, Inc.
CTLT
4.16%
Merck & Co., Inc.
MRK
3.816%
Elanco Animal Health Incorporated
ELAN
2.887%
Intra-Cellular Therapies, Inc.
ITCI
2.706%
Organon & Co.
OGN
2.091%
Prestige Consumer Healthcare Inc.
PBH
1.426%
Axsome Therapeutics, Inc.
AXSM
1.389%
Corcept Therapeutics Incorporated
CORT
1.189%
Supernus Pharmaceuticals, Inc.
SUPN
0.719%
Ligand Pharmaceuticals Incorporated
LGND
0.663%
Amphastar Pharmaceuticals, Inc.
AMPH
0.659%
Arvinas, Inc.
ARVN
0.65%
Cassava Sciences, Inc.
SAVA
0.505%
Collegium Pharmaceutical, Inc.
COLL
0.468%
Edgewise Therapeutics, Inc.
EWTX
0.466%
Harmony Biosciences Holdings, Inc.
HRMY
0.43%
Innoviva, Inc.
INVA
0.406%
Amneal Pharmaceuticals, Inc.
AMRX
0.367%
ANI Pharmaceuticals, Inc.
ANIP
0.355%
Tarsus Pharmaceuticals, Inc.
TARS
0.314%
Pliant Therapeutics, Inc.
PLRX
0.267%
Revance Therapeutics, Inc.
RVNC
0.261%
Pacira BioSciences, Inc.
PCRX
0.26%
Nuvation Bio Inc.
NUVB
0.178%